Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

The molecular changes driving the carcinogenesis in Barrett's esophagus: which came first, the chicken or the egg?

Russo A, Bronte G, Cabibi D, Bazan V, Cicero G, Bertani A, Rizzo S, Fiorentino E.

Crit Rev Oncol Hematol. 2013 Jun;86(3):278-89. doi: 10.1016/j.critrevonc.2012.12.001. Epub 2013 Jan 4. Review.

PMID:
23290822
[PubMed - indexed for MEDLINE]
2.

Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus.

Dolan K, Morris AI, Gosney JR, Field JK, Sutton R.

J Gastroenterol Hepatol. 2003 Jun;18(6):683-9.

PMID:
12753151
[PubMed - indexed for MEDLINE]
3.

Barrett's esophagus: can biomarkers predict progression to malignancy?

Tischoff I, Tannapfel A.

Expert Rev Gastroenterol Hepatol. 2008 Oct;2(5):653-63. doi: 10.1586/17474124.2.5.653. Review.

PMID:
19072343
[PubMed - indexed for MEDLINE]
4.

Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma.

Helm J, Enkemann SA, Coppola D, Barthel JS, Kelley ST, Yeatman TJ.

Clin Cancer Res. 2005 Apr 1;11(7):2478-85.

PMID:
15814623
[PubMed - indexed for MEDLINE]
Free Article
5.

Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma.

Pizzi M, Fassan M, Realdon S, Balistreri M, Battaglia G, Giacometti C, Zaninotto G, Zagonel V, De Boni M, Rugge M.

Hum Pathol. 2012 Nov;43(11):1839-44. doi: 10.1016/j.humpath.2012.01.004. Epub 2012 Apr 20.

PMID:
22521076
[PubMed - indexed for MEDLINE]
6.

Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.

Kimchi ET, Posner MC, Park JO, Darga TE, Kocherginsky M, Karrison T, Hart J, Smith KD, Mezhir JJ, Weichselbaum RR, Khodarev NN.

Cancer Res. 2005 Apr 15;65(8):3146-54.

PMID:
15833844
[PubMed - indexed for MEDLINE]
Free Article
7.

MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.

Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG, Hofstetter WL, Rashid A, Luthra R.

Am J Pathol. 2009 May;174(5):1940-8. doi: 10.2353/ajpath.2009.080718. Epub 2009 Mar 26.

PMID:
19342367
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.

Fang Y, Chen X, Bajpai M, Verma A, Das KM, Souza RF, Garman KS, Donohoe CL, O'Farrell NJ, Reynolds JV, Dvorak K.

Ann N Y Acad Sci. 2013 Oct;1300:187-99. doi: 10.1111/nyas.12249. Review.

PMID:
24117642
[PubMed - indexed for MEDLINE]
9.

Barrett's esophagus and risk of esophageal adenocarcinoma.

Cossentino MJ, Wong RK.

Semin Gastrointest Dis. 2003 Jul;14(3):128-35. Review.

PMID:
14653412
[PubMed - indexed for MEDLINE]
10.

Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.

Revilla-Nuin B, Parrilla P, Lozano JJ, de Haro LF, Ortiz A, Martínez C, Munitiz V, de Angulo DR, Bermejo J, Molina J, Cayuela ML, Yélamos J.

Ann Surg. 2013 May;257(5):886-93. doi: 10.1097/SLA.0b013e31826ddba6.

PMID:
23059500
[PubMed - indexed for MEDLINE]
11.

Barrett's esophagus, dysplasia, and adenocarcinoma.

Haggitt RC.

Hum Pathol. 1994 Oct;25(10):982-93. Review.

PMID:
7927321
[PubMed - indexed for MEDLINE]
12.

Molecular biology of Barrett's adenocarcinoma.

Wijnhoven BP, Tilanus HW, Dinjens WN.

Ann Surg. 2001 Mar;233(3):322-37. Review.

PMID:
11224619
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Surveillance in Barrett's esophagus: an audit of practice.

Ajumobi A, Bahjri K, Jackson C, Griffin R.

Dig Dis Sci. 2010 Jun;55(6):1615-21. doi: 10.1007/s10620-009-0917-y. Epub 2009 Aug 11.

PMID:
19669878
[PubMed - indexed for MEDLINE]
14.

Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.

Schneider PM, Casson AG, Levin B, Garewal HS, Hoelscher AH, Becker K, Dittler HJ, Cleary KR, Troster M, Siewert JR, Roth JA.

J Thorac Cardiovasc Surg. 1996 Feb;111(2):323-31; discussion 331-3.

PMID:
8583805
[PubMed - indexed for MEDLINE]
15.

Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.

Agarwal A, Polineni R, Hussein Z, Vigoda I, Bhagat TD, Bhattacharyya S, Maitra A, Verma A.

Int J Clin Exp Pathol. 2012;5(5):382-96. Epub 2012 May 23. Review.

PMID:
22808291
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.

Kan T, Meltzer SJ.

Curr Opin Pharmacol. 2009 Dec;9(6):727-32. doi: 10.1016/j.coph.2009.08.009. Epub 2009 Sep 19. Review.

PMID:
19773200
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus.

Dolan K, Garde J, Walker SJ, Sutton R, Gosney J, Field JK.

Hum Pathol. 1999 Dec;30(12):1508-14.

PMID:
10667431
[PubMed - indexed for MEDLINE]
18.

Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis.

Fassan M, Pizzi M, Battaglia G, Giacomelli L, Parente P, Bocus P, Ancona E, Rugge M.

J Clin Pathol. 2010 Aug;63(8):692-6. doi: 10.1136/jcp.2010.078253. Erratum in: J Clin Pathol. 2011 Mar;64(3):274.

PMID:
20702469
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Inflammation and Barrett's carcinogenesis.

Poehlmann A, Kuester D, Malfertheiner P, Guenther T, Roessner A.

Pathol Res Pract. 2012 May 15;208(5):269-80. doi: 10.1016/j.prp.2012.03.007. Epub 2012 Apr 27. Review.

PMID:
22541897
[PubMed - indexed for MEDLINE]
20.

Genetic alterations in Barrett's esophagus and esophageal adenocarcinoma.

Dinjens WN.

Minerva Chir. 2002 Dec;57(6):733-52. Review.

PMID:
12592217
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk